| PEGCETACOPLAN | APELLIS PHARMS | ||
| 150MG/ML ; Solution |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| SYFOVRE is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). | |||
|
Yes
| |||
| SYFOVRE | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||
| ****** ** ******** ***-******* ******* ************ ********** ************* * ********** ****** | ******* ** ******** ***-******* ******* ************ ** ********** *** ******* ******* | ****** ********** ******* | ****** ********** ******* | ********** ******* **** ******** ******** | ****-********, ****-******, ** ******** ********** ******* *** **** ******* | ****-********, ****-******, ** ******** ********** ******* *** **** ******* | ****-********, ****-******, ** ******** ********** ******* *** ******* ************ *** ******* | ****-********, ****-******, ** ******** ********** ******* *** ******* ************ *** ******* | ****-********, ****-******, ** ******** ********** ******* *** ******* ************ *** ******* | ****** ******** | ****** ******** | ****** ******** *** ******* ************ *** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|